Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways

Area of Science:

• Neuroscience
• Molecular Biology
• Epigenetics

Background:

• Brain-derived neurotrophic factor (BDNF) is crucial for neuronal survival, growth, and synaptic plasticity.
• Alzheimer's disease is characterized by neuronal and synaptic loss.

Purpose of the Study:

• To investigate the effect of sulforaphane on neuronal BDNF expression and associated synaptic signaling pathways.
• To explore the potential of sulforaphane in preventing neurodegenerative disorders.

Main Methods:

• Utilized mouse primary cortical neurons and a triple-transgenic mouse model of Alzheimer's disease (3 × Tg-AD).
• Assessed levels of BDNF, synaptic markers (MAP2, synaptophysin, PSD-95), and TrkB signaling components (CREB, CaMKII, ERK, Akt).
• Investigated epigenetic modifications including histone acetylation, HDAC activity, and HDAC2 levels, using chromatin immunoprecipitation.

Main Results:

• Sulforaphane significantly enhanced neuronal BDNF expression and increased levels of key neuronal and synaptic molecules.
• Elevated levels of TrkB signaling pathway components were observed following sulforaphane treatment.
• Sulforaphane inhibited HDAC activity, increased histone H3 and H4 acetylation at BDNF promoters, suggesting epigenetic regulation.

Conclusions:

• Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways.
• These findings indicate sulforaphane's potential therapeutic role in preventing neurodegenerative diseases like Alzheimer's.